LIV Body identifies itself as the platform (LivBody HoldCo LLC, 317 6th Avenue, Suite 400, Des Moines, Iowa 50309)
What to Expect Going Forward Interest in retatrutide continues to grow, and research around metabolic therapies is moving quickly
However, the results may signal that as GLP-1 use becomes more widespread, preferences could gradually shift away from highly energy-dense and ultra-processed products towards foods with lower energy density and higher protein content
This does not mean you need to force large meals or follow a complicated diet
Lixisenatide is a modified exendin-4 in which proline has been deleted from the C-terminal end and six lysines have been added (Fig
At higher doses, patients lost an average of nearly a quarter of their body weight, exceeding outcomes typically reported with current licensed treatments such as Wegovy (~15%) or Mounjaro (~20%)